Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
MOTS-c Pathway (Systemic Energy Sensor): Cellular Stress / Exercise Mitochondria release MOTS-c Travels to Nucleus Activates AMPK Result: Increased Insulin Sensitivity + Enhanced ATP Production + Systemic Fat Oxidation 5-Amino-1MQ Pathway (Targeted Fat Burner): High-Fat Diet / Aging 5-Amino-1MQ enters Adipocytes (Fat Cells) Blocks NNMT Enzyme Result: NAD+ Levels Skyrocket Forced Lipolysis (Fat Burning) + Prevention of Fat Storage Why MOTS-c Might Be "Better" Experimental findings show that MOTS-c provides broad, systemic metabolic benefits
Unlike oral supplements, which must pass through the digestive system, injections provide direct delivery into the bloodstream
FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List
Many patients are highly satisfied with injection therapy due to its effectiveness when other treatments fail
This prevents a full independent assessment of randomization, attrition, subgroup analyses, multiplicity, exposure-response behavior, and complete adverse-event reporting
A short series may be suggested if your starting level is low
